FR2349328B1 - - Google Patents

Info

Publication number
FR2349328B1
FR2349328B1 FR7612942A FR7612942A FR2349328B1 FR 2349328 B1 FR2349328 B1 FR 2349328B1 FR 7612942 A FR7612942 A FR 7612942A FR 7612942 A FR7612942 A FR 7612942A FR 2349328 B1 FR2349328 B1 FR 2349328B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7612942A
Other languages
French (fr)
Other versions
FR2349328A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7612942A priority Critical patent/FR2349328A1/fr
Priority to SE7704616A priority patent/SE436037B/xx
Priority to HURO000924 priority patent/HU178333B/hu
Priority to AR267416A priority patent/AR222627A1/es
Priority to GB18082/77A priority patent/GB1538842A/en
Priority to DK187677A priority patent/DK187677A/da
Priority to BE177138A priority patent/BE854113A/xx
Priority to NL7704758A priority patent/NL7704758A/xx
Priority to CH541177A priority patent/CH620675A5/fr
Priority to DE19772719244 priority patent/DE2719244A1/de
Priority to CA277,423A priority patent/CA1100493A/fr
Priority to JP5061277A priority patent/JPS52148048A/ja
Priority to IE885/77A priority patent/IE45141B1/en
Priority to AU24795/77A priority patent/AU511408B2/en
Priority to US05/792,563 priority patent/US4119727A/en
Priority to AT310177A priority patent/AT355739B/de
Priority to LU77240A priority patent/LU77240A1/xx
Publication of FR2349328A1 publication Critical patent/FR2349328A1/fr
Application granted granted Critical
Publication of FR2349328B1 publication Critical patent/FR2349328B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7612942A 1976-04-30 1976-04-30 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments Granted FR2349328A1 (fr)

Priority Applications (17)

Application Number Priority Date Filing Date Title
FR7612942A FR2349328A1 (fr) 1976-04-30 1976-04-30 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments
SE7704616A SE436037B (sv) 1976-04-30 1977-04-21 Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat
HURO000924 HU178333B (en) 1976-04-30 1977-04-27 Process for producing 11-deoxy-prostaglandine f2 derivatives
DE19772719244 DE2719244A1 (de) 1976-04-30 1977-04-29 Neue derivate des 11-desoxy-prostaglandin-f tief 2 , verfahren zu deren herstellung und pharmazeutische zusammensetzungen
DK187677A DK187677A (da) 1976-04-30 1977-04-29 Fremgangsmade til fremstilling af derivater af 11-desoxyprostandin f2.
BE177138A BE854113A (fr) 1976-04-30 1977-04-29 Nouveaux derives de la 11-desoxy prostaglandine f2, procede de preparation et compositions pharmaceutiques
NL7704758A NL7704758A (nl) 1976-04-30 1977-04-29 Werkwijze voor de bereiding van nieuwe ver- bindingen van 11-desoxyprostaglandine f2.
CH541177A CH620675A5 (pt) 1976-04-30 1977-04-29
AR267416A AR222627A1 (es) 1976-04-30 1977-04-29 Procedimiento para la preparacion de los nuevos derivados de acido(8rs,9rs,12rs,15rs)(5z,13e)9,15-dihidroxi 16-sustituido-18,19,20-trinor(o 17,18,19,20-tetranor)prosta 5,13-dienoico e intermediarios para su uso exclusivo en dicho procedimiento
CA277,423A CA1100493A (fr) 1976-04-30 1977-04-29 Procede de preparation de nouveaux derives de la 11- desoxy prostaglandine f.sub.2
GB18082/77A GB1538842A (en) 1976-04-30 1977-04-29 Prostaglandin derivatives
JP5061277A JPS52148048A (en) 1976-04-30 1977-04-30 New 111deoxyprostaglandin f2 derivative* process for manufacture and pharmaceutical compositions thereof
IE885/77A IE45141B1 (en) 1976-04-30 1977-05-02 Prostaglandin derivatives
AU24795/77A AU511408B2 (en) 1976-04-30 1977-05-02 11-desoxy prostaglandin f2 derivatives
US05/792,563 US4119727A (en) 1976-04-30 1977-05-02 Novel 11-desoxy-prostaglandin F2 derivatives
AT310177A AT355739B (de) 1976-04-30 1977-05-02 Verfahren zur herstellung neuer derivate des 11-desoxy prostaglandins f2
LU77240A LU77240A1 (pt) 1976-04-30 1977-05-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7612942A FR2349328A1 (fr) 1976-04-30 1976-04-30 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
FR2349328A1 FR2349328A1 (fr) 1977-11-25
FR2349328B1 true FR2349328B1 (pt) 1978-08-25

Family

ID=9172539

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7612942A Granted FR2349328A1 (fr) 1976-04-30 1976-04-30 Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments

Country Status (3)

Country Link
BE (1) BE854113A (pt)
FR (1) FR2349328A1 (pt)
HU (1) HU178333B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4024347A1 (de) * 1990-07-27 1992-01-30 Schering Ag Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Also Published As

Publication number Publication date
HU178333B (en) 1982-04-28
BE854113A (fr) 1977-10-31
FR2349328A1 (fr) 1977-11-25

Similar Documents

Publication Publication Date Title
DE2704841C2 (pt)
DE2733819C2 (pt)
DE2704078C2 (pt)
DE2639718C2 (pt)
DE2652978C3 (pt)
FR2359332B3 (pt)
DE2601335C2 (pt)
DE2647716C2 (pt)
JPS5618182Y2 (pt)
JPS5337303B2 (pt)
JPS52162588U (pt)
DE2652863C2 (pt)
FR2349328B1 (pt)
FR2354514B1 (pt)
JPS5522059B2 (pt)
JPS52139376U (pt)
JPS52135512U (pt)
JPS52136371U (pt)
JPS52143453U (pt)
JPS5344159U (pt)
DE2616174C2 (pt)
CS177793B1 (pt)
JPS52140882U (pt)
JPS52153975U (pt)
JPS52161044U (pt)

Legal Events

Date Code Title Description
ST Notification of lapse